Prosthesis Guided Speech Rehabilitation of T1/T2 Cancers of the Tongue
Part of paid clinical trials in Ann Arbor, Michigan.
- Sponsor
- University of Michigan
- Study ID
- NCT02584270
- Status
- Recruiting
Conditions
- Oral Cancer
- Tongue Cancer
- Tongue Neoplasms
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Palatal Augmentation Prosthesis (PAP) — DEVICEThe palatal augmentation prosthesis, or PAP can improve speech and swallowing functions through reshaping the palatal contours. This may improve the contact between the tongue and hard palate as a person speaks or eats. It is meant to be created after adequate healing in patients with adequate motivation for improvements in their speech and swallowing. Regular wear and articulation therapy are necessary for this therapy to be effective.
- Articulation Therapy — OTHERSubjects will receive the standard of care speech and articulation therapy in either arm.
Study Details
This study will fill a scientific gap in the current knowledge providing data for evaluation of the palatal augmentation prosthesis (PAP) as a therapeutic modality post-surgery. This is a robust scientific randomized prospective clinical trial. Positive outcomes from this study have the potential to dramatically alter the most common issues of oral cancer therapy, namely speech and swallowing functions. Patients will have been diagnosed with a cancer lesion of the tongue requiring surgery and removal of part of the tongue. Smaller cancers of the tongue are sized as T1 or T2. For patients with smaller lesions, a PAP, which can aid in speaking and swallowing, is not routinely provided.
Key Dates
- Start date
- Jan 2, 2018
- Status verified
- May 2026
- Primary completion
- Jan 31, 2028
- Completion
- Jun 30, 2028
Study Design
- Enrollment
- 40 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Prosthesis + Articulation TherapyThis arm will receive a PAP (palatal augmentation prosthesis) with standard articulation therapy. This is the study arm
- Other: No Prosthesis; Articulation Therapy OnlyThis arm will not receive a PAP (palatal augmentation prosthesis), but will receive standard articulation therapy. This is the control arm.
Primary Outcome Measure
Word intelligibility [ Time Frame: 6 months ]
Central Contacts
- Stephanie M Munz, DDS734 936-8289
- Mary Burton
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Michigan Department of Oral and Maxillofacial Surgery and Hospital Dentistry | Ann Arbor | Michigan | 48109 | Mary Burton |
Find similar trials in Ann Arbor, MI
Related Studies
- Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and NeckRecruiting · Ohio State University Comprehensive Cancer Center · Columbus, Ohio
- Microbiome in Head and Neck Squamous Cell CarcinomaRecruiting · University of Colorado, Denver · Aurora, Colorado
- Clinical and Molecular Features of Oral Premalignancy and Oral CancerRecruiting · M.D. Anderson Cancer Center · Houston, Texas
- Antibiotic Treatment Effects on Intratumoral Bacteria Modulation in Surgical Patients With Oral CancerPHASE2 · Recruiting · Case Comprehensive Cancer Center · Cleveland, Ohio